The American Skin Association has awarded UCLA’s Dr. Roger Lo the Abby S. and Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma Skin Cancer Research.
As part of the award, Lo, who is professor of dermatology and molecular and medical pharmacology in the David Geffen School of Medicine at UCLA and a member of UCLA’s Jonsson Comprehensive Cancer Center, with will receive $750,000 to help speed research discoveries for prevention, new treatments, and ultimately, a cure for the deadliest form of skin cancer.
Lo’s research focus is on genomic, epigenomic and immunologic factors that shape the cancer’s evolution on molecularly targeted therapies and/or immune checkpoint inhibitors. He has led research into resistance mechanisms against a promising class of drugs known as BRAF inhibitors and discovered ways to block multiple resistance routes and shrink tumors in people with advanced disease.
